Centenial Surgical Suture Ltd.

About

Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, centilene, and centsteel; and other medical devices that comprise centipunch, centcel, centiitape, centiiwax, centilene mesh, centipace, and centipled, as well as disposable surgical skin stapler. Centenial Surgical Suture Ltd. was incorporated in 1995 and is based in Thane, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	15.34	12.58	14.86	13.46	12.94	13.31	12.20	14.27	13.74	12.05	12.38	13.10	13.66
Expenses	13.16	11.65	13.33	12.07	11.71	11.25	11.45	12.54	12.02	10.54	11.19	11.96	12.50
Operating Profit	2.18	0.93	1.53	1.39	1.23	2.06	0.75	1.73	1.72	1.51	1.19	1.14	1.16
OPM %	14.21	7.39	10.30	10.33	9.51	15.48	6.15	12.12	12.52	12.53	9.61	8.70	8.49
Other Income	0.01	0.07	0.05	0.05	0.00	0.05	0.01	0.06	0.00	0.03	0.06	0.02	0.01
Depreciation	0.92	1.02	1.04	0.99	0.95	1.26	1.11	1.09	0.79	0.44	0.33	0.32	0.30
Interest	0.29	2.21	0.35	0.46	0.32	2.19	0.50	0.53	0.53	0.95	0.51	0.52	0.48
Profit before tax	0.98	-2.23	0.19	-0.01	-0.04	-1.34	-0.85	0.17	0.40	0.15	0.41	0.32	0.39
Tax %	25.51	4.04	26.32	0.00	0.00	-11.19	0.00	23.53	25.00	-26.67	24.39	28.12	25.64
Net Profit	0.74	-2.31	0.15	-0.01	-0.04	-1.18	-0.85	0.13	0.30	0.19	0.31	0.24	0.29
EPS in Rs	2.03	-6.33	0.41	-0.03	-0.11	-3.23	-2.33	0.36	0.82	0.52	0.85	0.66	0.79

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	53.84	53.49	51.19	52.66	44.43	36.93	55.61	56.05	52.73	52.84	51.39	51.71
Expenses	48.75	47.07	46.04	48.26	39.94	31.82	49.68	50.64	48.26	47.95	46.71	46.47
Operating Profit	5.09	6.42	5.15	4.40	4.49	5.11	5.93	5.41	4.47	4.89	4.68	5.24
OPM %	9.45	12.00	10.06	8.36	10.11	13.84	10.66	9.65	8.48	9.25	9.11	10.13
Other Income	0.17	0.12	0.13	0.13	0.04	0.09	0.09	0.02	0.05	0.01	0.02	0.10
Interest	3.34	3.90	2.62	1.77	1.93	2.12	2.31	1.89	1.51	1.77	1.65	1.61
Depreciation	4.00	4.25	1.39	1.30	1.53	1.55	1.55	0.69	0.60	0.59	0.68	0.83
Profit before tax	-2.08	-1.61	1.27	1.46	1.07	1.53	2.16	2.85	2.41	2.54	2.37	2.90
Tax %	6.25	-9.32	11.02	39.73	42.06	37.25	39.81	29.12	36.10	32.68	34.18	34.14
Net Profit	-2.20	-1.46	1.13	0.89	0.63	0.96	1.30	2.02	1.54	1.72	1.56	1.92
EPS in Rs	-6.03	-4.00	3.10	2.44	1.73	2.63	3.56	5.54	4.22	4.71	4.28	5.26
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	5.42	5.42	5.42	5.42	5.42	5.42	5.42	5.42	5.42	5.42	5.42	5.42
Reserves	23.13	25.33	26.79	25.66	24.77	24.15	23.18	22.63	20.62	19.07	17.35	15.79
Borrowings	10.71	30.01	23.24	9.92	9.30	13.47	12.72	13.10	14.37	15.24	13.11	12.28
Other Liabilities	40.53	23.83	23.70	25.40	21.85	27.00	27.96	15.61	14.89	16.07	16.68	21.80
Total Liabilities	79.79	84.59	79.15	66.40	61.34	70.04	69.28	56.76	55.30	55.80	52.56	55.29
Fixed Assets	18.22	19.99	12.77	6.46	7.60	8.97	10.44	4.08	3.80	3.71	3.64	4.13
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.22	0.22	0.19	0.19	0.19
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	61.57	64.60	66.38	59.94	53.74	61.07	58.62	52.46	51.28	51.90	48.73	50.97
Total Assets	79.79	84.59	79.15	66.40	61.34	70.04	69.28	56.76	55.30	55.80	52.56	55.29

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	7.28	17.07	6.21	1.30	4.75	1.97	2.08	1.55	1.76	0.00	-1.51	0.21
Cash from Investing Activity	-2.41	-11.61	-7.92	-0.18	-0.17	-0.89	-1.31	-1.02	-0.64	-2.38	-0.19	-0.36
Cash from Financing Activity	-4.89	-5.93	2.06	-1.05	-4.87	-1.27	-0.37	-1.27	-0.88	2.14	0.82	0.96
Net Cash Flow	-0.02	-0.47	0.35	0.07	-0.28	-0.18	0.40	-0.75	0.24	-0.25	-0.88	0.80
Free Cash Flow	5.05	5.60	-1.49	1.14	4.59	1.13	1.00	0.57	1.05	-0.66	-1.70	-0.15
CFO/OP %	144.00	270.00	129.00	42.00	112.00	50.00	50.00	44.00	59.00	0.00	-15.00	23.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	123.93	125.56	134.05	142.71	160.44	221.39	153.26	134.80	125.29	130.76	132.75	138.21
Inventory Days	791.32	921.61	909.72	677.26	599.23	1,276.44	483.86	434.68	465.89	468.59	365.93	350.07
Days Payable	145.61	151.98	207.75	222.42	159.00	372.75	187.98	120.26	135.64	146.28	124.26	167.34
Cash Conversion Cycle	769.64	895.19	836.02	597.56	600.67	1,125.08	449.14	449.22	455.54	453.06	374.42	320.94
Working Capital Days	191.58	210.99	226.67	207.73	236.68	282.37	172.36	167.69	164.05	156.25	148.80	127.27
ROCE %	2.52	3.94	8.07	8.03	7.27	8.65	10.84	11.62	9.78	11.40	11.59	14.08

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89
Public	53.11	53.11	53.11	53.11	53.11	53.11	53.11	53.12	53.12	53.12	53.12	53.12
No. of Shareholders	1,165	1,182	1,200	1,193	1,186	1,206	1,186	1,163	1,159	1,072	1,016	947